| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/21/2006 | US20060287286 Prophylaxis of respiratory disorders and therapy, also metod of synthesis and composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent |
| 12/21/2006 | US20060287284 Pharmaceutical composition combining tenatoprazole and an anti-inflamatory agent |
| 12/21/2006 | US20060287275 Using 5'-sulfoxyoxy adenosine in therapy for tachycardia, cardiovascular disorders, angina, myocardial infraction , antilipemic agents |
| 12/21/2006 | US20060287246 Remedy for eye diseases accompanied by optic nerve injuries |
| 12/21/2006 | US20060287235 Crystallization of IGF-1 |
| 12/21/2006 | US20060287230 Compositions which can be used for regulating the activity of parkin |
| 12/21/2006 | US20060286163 Pharmaceutical composition of topiramate |
| 12/21/2006 | US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | US20060286043 Delivery of antihistamines through an inhalation route |
| 12/21/2006 | US20060286042 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 12/21/2006 | US20060286040 Medicament compositions comprising a heterocyclic compound and an anticholinergic |
| 12/21/2006 | DE102005014141B4 Tablettenförmige Retardzubereitung gegen Schwindel Delayed-release tablets shaped against scams |
| 12/21/2006 | CA2612413A1 Compounds for inhibition of 5-hydroxytryptamine and norepinephrine reuptake or for treatment of depression disorders, their preparation processes and uses thereof |
| 12/21/2006 | CA2612299A1 Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as orl1-receptor antagonists |
| 12/21/2006 | CA2612298A1 Anti-inflammatory agents |
| 12/21/2006 | CA2612081A1 2,5-bis-diamimne [1 , 4] benzoquinone-derivatives |
| 12/21/2006 | CA2611917A1 Injection |
| 12/21/2006 | CA2611376A1 Therapeutic agents |
| 12/21/2006 | CA2611216A1 3-phenylazetidine derivatives as dopamine agonists |
| 12/21/2006 | CA2611054A1 Novel a.beta.-binding protein and its peptide derivatives and uses thereof |
| 12/21/2006 | CA2609577A1 Benztropinamine analogs as dopamine uptake inhibitors |
| 12/21/2006 | CA2607054A1 1, 2-di(cyclic group)substituted benzene derivative |
| 12/21/2006 | CA2550704A1 Nicotine transdermal delivery system |
| 12/20/2006 | EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative |
| 12/20/2006 | EP1734039A1 Aryl urea compounds as BETA-secretase inhibitors |
| 12/20/2006 | EP1734037A2 Processes for the preparation of (R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol" |
| 12/20/2006 | EP1733740A1 Therapeutic agent for auris interna disorder containing il-6 antagonist as active ingredient |
| 12/20/2006 | EP1733737A1 Axon regeneration promoter |
| 12/20/2006 | EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase |
| 12/20/2006 | EP1733727A1 Ferrocenecarboxamide derivatives for use as dopamine D3 ligands for the treatment of CNS disorders |
| 12/20/2006 | EP1733724A1 Amino alcohol compound |
| 12/20/2006 | EP1733722A1 Memory fixation accelerator |
| 12/20/2006 | EP1733721A2 Use of astaxanthin or esters thereof as a phosphodiesterase inhibitor |
| 12/20/2006 | EP1733631A1 Food composition having antistress effect |
| 12/20/2006 | EP1733237A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara) |
| 12/20/2006 | EP1732917A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 12/20/2006 | EP1732896A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp) |
| 12/20/2006 | EP1732892A1 Tetrahydrocarbazoles and derivatives |
| 12/20/2006 | EP1732883A1 Novel urea derivatives and their medical use |
| 12/20/2006 | EP1732649A1 Treatment of neurodegenerative diseases by the use of laptm4b |
| 12/20/2006 | EP1732648A2 Treatment of diseases |
| 12/20/2006 | EP1732563A1 Methods for modulating glutamate receptors for treating neuropsychiatric disorders comprising the use of modulators of serum and glucocorticoid inducible kinases |
| 12/20/2006 | EP1732559A2 Methods of treatment using eszopiclone |
| 12/20/2006 | EP1732558A1 1-[2h-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of pain |
| 12/20/2006 | EP1732557A1 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of movement disorders |
| 12/20/2006 | EP1732556A1 Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and hydrates thereof |
| 12/20/2006 | EP1732555A1 Opioid delivery system |
| 12/20/2006 | EP1732550A2 Dpp-iv inhibitors for treating neurodegeneration and cognitive disorders |
| 12/20/2006 | EP1732545A1 Tetrahydro-beta-carboline compounds and use thereof |
| 12/20/2006 | EP1732541A2 Cyclic compounds |
| 12/20/2006 | EP1732531A2 Amines and amides for the treatment of diseases |
| 12/20/2006 | EP1732530A1 1-aminovyclohexane derivatives for the treatment of agitation and other behavioral disorders, especially those associated with alzheimer's disease |
| 12/20/2006 | EP1732514A1 Crystalline composition containing escitalopram oxalate |
| 12/20/2006 | EP1631557B1 Cyclic hydroxylamine as psychoactive compounds |
| 12/20/2006 | EP1542977B1 2,5-dioxoimidazolidin-4-yl acetamides and analogues as inhibitors of metalloproteinase mmp12. |
| 12/20/2006 | EP1523335B1 Injectable depot formulation comprising crystals of iloperidone |
| 12/20/2006 | EP1509501B1 1-(aminoalkyl)-3-sulfonylindole and -indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 12/20/2006 | EP1506200B1 Diazabicyclic biaryl derivatives |
| 12/20/2006 | EP1441726B1 Derivatives of phenoxy-n-'4-(isothiazolidin-1,1-dioxid-2yl)pheny]-valerian- acid amide and other compounds as inhibitors of the coagulation factor xa in the treatment of thromboembolic diseases and tumors |
| 12/20/2006 | EP1438310B1 Beta-carbolin derivatives as ptp-inhibitors |
| 12/20/2006 | EP1434762B1 4'-methanesulfonyl-biphenyl derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 12/20/2006 | EP1401809B1 Tryptase inhibitors |
| 12/20/2006 | EP1392314B1 NOVEL USE OF 2-[2-Ethoxy-5-(4-methyl-piperazin-1-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-on |
| 12/20/2006 | EP1390362B1 Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists |
| 12/20/2006 | EP1379235B1 Compositions and methods for enhancing paracellular permeability across epithelial and endothelial barriers |
| 12/20/2006 | EP1357935B1 Reducing side effects of chemotherapy in cancer patients |
| 12/20/2006 | EP1357903B1 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY|PHENOXY)-2-(4-METHOXYPHENYL) BENZO b|THIOPHENE AND SALTS THEREOF |
| 12/20/2006 | EP1317537B1 G-csf analog compositions and methods |
| 12/20/2006 | EP1263729B1 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 12/20/2006 | EP1256344B1 Remedies for endothelin-induced diseases |
| 12/20/2006 | EP1202967B1 Sulfuric acid mono-[3-({1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester |
| 12/20/2006 | EP1194164B1 Prion protein peptides and uses thereof |
| 12/20/2006 | EP1131294B1 Quinoline derivatives as nk-2 and nk-3 receptor ligands |
| 12/20/2006 | EP0966442B1 Quinoline and quinazoline derivatives having corticotropin releasing factor (crf) antagonist activity |
| 12/20/2006 | EP0836476B1 A COSMETIC COMPOSITION comprising the glycopropyl ester of retinoic acid FOR SKIN APPLICATIONS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF skin diseases, TUMOROUS CELLS, BLADDER OR NERVE DISORDERS |
| 12/20/2006 | CN2848220Y Fever downing refreshment plaster |
| 12/20/2006 | CN1882590A Fused heterocyclic compounds as serotonin receptor modulators |
| 12/20/2006 | CN1882587A Use of tricyclic compounds as glycine transport inhibitors |
| 12/20/2006 | CN1882584A 4-substituted imidazoles |
| 12/20/2006 | CN1882583A 5-substituted imidazoles |
| 12/20/2006 | CN1882581A Derivatives of n-[heteroaryl(piperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 12/20/2006 | CN1882574A Pyrazolyl and imidazolyl pyrimidines |
| 12/20/2006 | CN1882564A Indazol-3-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (vr1) |
| 12/20/2006 | CN1882541A derivatives of n-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics |
| 12/20/2006 | CN1882540A Derivatives of n-phenyl(piperidine-2-yl)methyl benzamide, preparation method thereof and applications of same in therapeutics |
| 12/20/2006 | CN1882538A Substituted sulfonamide-indole-2-carboxylic acid derivatives as PAI-1 inhibitors |
| 12/20/2006 | CN1882534A Derivatives of n-[phenyl(pyrrolidine-2-yl)methyl]benzamide and n-[(azepan-2-yl)phenylmethyl]benzamide, preparation method thereof and application of same in therapeutics |
| 12/20/2006 | CN1882375A Treatment of amyloid- and epileptogenesis-associated diseases |
| 12/20/2006 | CN1882352A Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
| 12/20/2006 | CN1882340A Method and composition for treatment or prophylaxis of amyloidosis disorders |
| 12/20/2006 | CN1882325A Novel use of peptide compounds for treating central neuropathic pain |
| 12/20/2006 | CN1880328A Preparation method of hyperin and hypericin of Hypericum perforatum |
| 12/20/2006 | CN1880306A Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 12/20/2006 | CN1879881A Yeast vaccine production method |
| 12/20/2006 | CN1879876A Neurotrophic factor slow release microsphere and its preparation method |
| 12/20/2006 | CN1879867A Formulation and its preparation process |
| 12/20/2006 | CN1879840A A nano 'Xing Nao Jing' injection and method for preparing same |
| 12/20/2006 | CN1879837A Medicine for stopping smoking |
| 12/20/2006 | CN1879820A Chinese herbal medicine for treating schizophrenia |